Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 2c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Zimmer Biomet (ZBH) PT Lowered to $130 at Stifel
August 7, 2024 2:03 PM EDTStifel analyst Rick Wise lowered the price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $135.00) while maintaining a Buy rating.
The analyst comments "We left Zimmer's 2Q24 earnings call better-appreciating the many fundamental positives and sales growth drivers. We were reminded that over... More
